MediGene starts up new UK company
This article was originally published in Scrip
Executive Summary
MediGeneand three private investors have founded Immunocore to concentrate on the monoclonal T-cell receptor (mTCR) platform, which was previously the focus of the company's UK subsidiary MediGene Ltd.